Brains were extracted and placed in RNAlater solution for storage before RNA extraction. The brain tissue was weighed and then homogenized in 1 mL TRIzol per 100 mg tissue. Separation of DNA and proteins was then performed using 200 μL chloroform per 100 mg tissue and centrifugation. Once the RNA was isolated, a series of wash steps using isopropyl alcohol and ethanol was performed to precipitate pure RNA. The purity of the RNA samples was assessed using Nano Drop (ND-1000, Thermo Fisher, Waltham, MA, USA). Reverse transcription was performed using 2500 ng total RNA and 4 μL of reagent (SuperScript™ IV VILO™ (SSIV VILO) Master Mix, Thermo Fisher, Waltham, MA, USA). Primers were annealed for 10 min at 25 °C, incubated for 10 min at 50 °C, and then at 95 °C for 5 min. The volume of cDNA was diluted to obtain 100 μL of 20 ng/μL cDNA. Once the cDNA was isolated, qRT-PCR was performed with Fast SYBR Green Master Mix (Thermo Fisher, Waltham, MA, USA) by a StepOnePlus RealTime PCR System. iTaq Supermix, cDNA, and forward/reverse primers for each respective cytokine were prepared and kept on ice with a total reaction mix volume of 10μL including 20 ng of cDNA. The reactions were loaded into triplicate wells and loaded into a CFX RT-PCR system. The expression of GAPDH mRNA was used to normalize target gene expression levels, and the P14 age group of mGluR5+/+ was used as the control for comparative cycle threshold (2−ΔΔCt) calculations. All gene expression levels were normalized and are expressed as the relative fold change to the housekeeping gene of the control condition.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.